ArticleDrug safety2022
Artificial Intelligence and Machine Learning for Safe Medicines.
Article in Drug safety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Drug-induced adverse events in modern pharmacotherapy: mechanisms, clinical manifestations, and implications for risk assessment and management.Frontiers in pharmacology · 2026Review
- How is AI developing in pharmacovigilance?Therapeutic advances in drug safety · 2026Article
- Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management.Clinical pharmacology and therapeutics · 2025Review
- Pharmacovigilance - Technological Advancements, Recent Developments and Innovations.Current drug safety · 2025Review
- Safety regulation of machine learning in cardiac surgery.Journal of thoracic disease · 2024Article
- Appeal for Increasing the Impact of Pharmacovigilance.Drug safety · 2024Article
- Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?Therapeutic advances in drug safety · 2024Article
- Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology.Frontiers in drug safety and regulation · 2024Article
- Trustworthy AI for safe medicines.Nature reviews. Drug discovery · 2023Article
- Evolution of Hybrid Intelligence and Its Application in Evidence-Based Medicine: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2023Review
- An industry perspective on the use of machine learning in drug and vaccine safety.Frontiers in drug safety and regulation · 2023Article
- Development and validation of a machine learning-based detection system to improve precision screening for medication errors in the neonatal intensive care unit.Frontiers in pharmacology · 2023Article
- Artificial intelligence in pharmacovigilance - Opportunities and challenges.Perspectives in clinical researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Authors' views on the role of artificial intelligence and machine learning in pharmacovigilance. (MP4 139807 kb).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.